Drug Pricing Executive Action Is Unlikely: Evercore ISIMark Melin
There is significant chatter in Washington D.C. that U.S. President Barack Obama could use his executive authority to regulate drug pricing, a “flash note” from Evercore ISI analyst Terry Haines says. But such an action is unlikely for three primary reasons, says the research note delivered to institutional investors earlier Wednesday.
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible